Skip to main content

Summary

for people ages up to 25 years (full criteria)
at Oakland, California and other locations
study started

Description

Summary

This research trial studies the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Official Title

The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

Details

PRIMARY OBJECTIVES:

  1. To maintain a Childhood Cancer Registry for infants, children, adolescents, and young adults with cancer.

II. To utilize clinical and biological data to help determine eligibility or stratification, based on childhood cancer disease classification schemas, for potential enrollment of research subjects onto Children's Oncology Group (COG) therapeutic clinical trials.

III. To develop a well annotated childhood cancer biobank for current and future research through the collection of biospecimens (at diagnosis, time of progression, time of recurrence and/or post-mortem), including tumor, host and when feasible parental germline deoxyribonucleic acid (DNA); and key clinical data, including presentation, diagnostic, staging, summary treatment, and outcome information, from every child diagnosed with cancer at COG institutions.

IV. To allow use of registry data for permission to be contacted in the future to consider participating in non-therapeutic and prevention research studies involving the child or their parents.

OUTLINE:

Patients undergo medical data review to create a Childhood Cancer Registry. Patients also undergo collection of bio-specimen samples (e.g., tissue, blood, bone marrow, plasma, serum, buccal cells, saliva, cerebrospinal fluid, or urine).

Keywords

Central Nervous System Neoplasm Childhood Lymphoma Childhood Relapsed Solid Tumor Nervous System Neoplasms Central Nervous System Neoplasms

Eligibility

For people ages up to 25 years

Inclusion Criteria:

  • Enrollment can occur at any time after disease presentation including at time of disease progression or recurrence; for patients who are to be enrolled on COG therapeutic studies, enrollment on APEC14B1 must occur prior to enrollment onto the therapeutic trial
  • Patients with a known or suspected neoplasm that occurs in the pediatric, adolescent or young adult populations are eligible for enrollment as follows:
  • All cancer cases with an International Classification of Diseases for Oncology(ICD-O) histologic behavior code of two "2" (carcinoma in situ) or three "3"(malignant)
  • All neoplastic lesions of the central nervous system regardless of behavior,i.e., benign, borderline or malignant
  • Other benign/borderline conditions including:
  • Mesoblastic nephroma
  • Teratomas
  • Myeloproliferative diseases including transient myeloproliferative disease
  • Langerhan cell histiocytosis
  • Lymphoproliferative diseases
  • Subjects must be =< 25 years of age at time of original diagnosis, except for patients who are being screened specifically for eligibility onto a COG (or COG participating National Clinical Trials Network (NCTN) ) therapeutic study, for whom there is a higher upper age limit
  • All patients or their parents or legally authorized representatives must sign a written informed consent; parents will be asked to sign a separate consent for their own biospecimen submission

Locations

  • Children's Hospital and Research Center at Oakland accepting new patients
    Oakland, California, 94609-1809, United States
  • UCSF Medical Center-Mission Bay accepting new patients
    San Francisco, California, 94158, United States
  • Kaiser Permanente-Oakland accepting new patients
    Oakland, California, 94611, United States
  • Children's Hospital Central California accepting new patients
    Madera, California, 93636-8762, United States
  • Lucile Packard Children's Hospital Stanford University accepting new patients
    Palo Alto, California, 94304, United States
  • University of California Davis Comprehensive Cancer Center accepting new patients
    Sacramento, California, 95817, United States
  • Sutter Medical Center Sacramento accepting new patients
    Sacramento, California, 95816, United States
  • Santa Barbara Cottage Hospital accepting new patients
    Santa Barbara, California, 93102, United States
  • Children's Hospital Los Angeles accepting new patients
    Los Angeles, California, 90027, United States
  • Cedars Sinai Medical Center accepting new patients
    Los Angeles, California, 90048, United States
  • City of Hope Comprehensive Cancer Center accepting new patients
    Duarte, California, 91010, United States
  • Southern California Permanente Medical Group accepting new patients
    Downey, California, 90242, United States
  • Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center accepting new patients
    Torrance, California, 90502, United States
  • Mattel Children's Hospital UCLA accepting new patients
    Los Angeles, California, 90095, United States
  • Miller Children's and Women's Hospital Long Beach accepting new patients
    Long Beach, California, 90806, United States
  • Children's Hospital of Orange County accepting new patients
    Orange, California, 92868, United States
  • Loma Linda University Medical Center currently not accepting new patients, but might later
    Loma Linda, California, 92354, United States
  • Summerlin Hospital Medical Center accepting new patients
    Las Vegas, Nevada, 89144, United States
  • University Medical Center of Southern Nevada accepting new patients
    Las Vegas, Nevada, 89102, United States
  • Children's Specialty Center of Nevada II accepting new patients
    Las Vegas, Nevada, 89109, United States
  • Sunrise Hospital and Medical Center accepting new patients
    Las Vegas, Nevada, 89109, United States

Details

Status
accepting new patients
Start Date
Sponsor
Children's Oncology Group
ID
NCT02402244
Study Type
Observational
Last Updated
November 28, 2017
I’m interested in this study!